February 13, 2017
Oxford BioDynamics welcomes Dr Claudio Carini to its Scientific Advisory Panel
Oxford BioDynamics, a biotechnology company focused on the discovery and development of novel epigenetic biomarkers for use within the pharmaceutical and biotechnology industry, has appointed Dr Claudio Carini as an Advisor, effective immediately.